Pharmaceutical Packaging Market by Type (Ampoules, Blister Packs, Caps & Closures), Delivery Mode (Injectables, IV Drugs, Nasal), Level of Packaging, Material, End User - Global Forecast 2024-2030
Pharmaceutical Packaging Market by Type (Ampoules, Blister Packs, Caps & Closures), Delivery Mode (Injectables, IV Drugs, Nasal), Level of Packaging, Material, End User - Global Forecast 2024-2030
The Pharmaceutical Packaging Market size was estimated at USD 156.87 billion in 2023 and expected to reach USD 173.13 billion in 2024, at a CAGR 10.06% to reach USD 307.05 billion by 2030.
Pharmaceutical packaging refers to the processes and materials used to encase and protect pharmaceutical products. It includes a range of container types like bottles, vials, blisters, tubes, syringes, ampoules, closures, labels, and secondary packaging materials. The packaging is designed to provide barrier protection, convenience in handling, and convey essential information about the medications. Pharmaceutical packaging has a critical role in ensuring the safety, quality, and efficacy of drugs. It serves numerous applications, including providing barrier protection against environmental factors and child resistance and accommodating the demands of specific modes of drug delivery. The primary end-users of pharmaceutical packaging are pharmaceutical manufacturers, healthcare providers, and patients. Growth in the pharmaceutical packaging market is influenced by several factors, such as growing smart packaging for patient engagement and identification, rising demand for primary pharmaceutical packaging, and increasing demand for biologics packaging. Moreover, stricter regulations for packaging in terms of child resistance and tamper-evidence boost innovation and compliance-related investments. However, the expansion of pharmaceutical packaging is hindered by the price volatility of pharmaceutical packaging raw materials, adherence to the global and local regulatory landscape, and meeting sustainability goals while maintaining the integrity of the packaging. On the other hand, the latest opportunities within the pharmaceutical packaging market include the evolution of nanotechnology due to innovative and new-generation packaging solutions, the emergence of eco-friendly and sustainable packaging solutions, and the customization of packaging for personalized treatment protocols.
Regional Insights
The United States stands as a prominent country for pharmaceutical packaging, driven by advanced healthcare infrastructure, stringent regulatory frameworks, and a high demand for drug delivery solutions. Regarding investments and initiatives, the US market is witnessing substantial growth in the biologics sector, necessitating sophisticated packaging solutions for sensitive products. Companies in the region continuously file patents for groundbreaking packaging designs and materials. In South America, rising healthcare expenditures and increasing access to healthcare services in countries such as Brazil and Argentina facilitate the growth of pharmaceutical packaging. The pharmaceutical packaging market in EU countries is highly regulated, focusing on patient safety and anti-counterfeiting measures. Patient-centric designs and adherence-compliant packaging are primary consumer needs across this region. Customers tend to favor packaging that integrates security features and promotes sustainability. EU initiatives often involve developing eco-friendly packaging materials and recycling programs. In wealthier nations within the Middle East, there is an increasing demand for high-quality pharmaceutical packaging that aligns with international standards. Africa, being a resource-limited setting, tends to focus on affordable and functional packaging solutions. However, there is an emerging focus on improving quality and counteracting counterfeit medications. The pharmaceutical packaging market in the APAC region is currently the fastest-growing globally due to rapidly developing healthcare sectors, increased healthcare spending, and a growing elderly population, especially in countries such as China, Japan, and Australia. The Chinese government's policies promoting innovation in pharmaceuticals have increased customer expectations for advanced packaging. Japan's pharmaceutical packaging market is developed, emphasizing precision, quality, and product integrity. The aging population leads to a consumer need for easy-to-use and senior-friendly packaging. India's pharmaceutical packaging market is characterized by cost-effectiveness due to the country's role as a significant exporter of generic drugs.
Market Insights
Market Dynamics
The market dynamics represent an ever-changing landscape of the Pharmaceutical Packaging Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
Market Drivers
Growing Smart Packaging for Patient Engagement and Identification
Growing Demand for Primary Pharmaceutical Packaging
Increasing Demand for Biologics Packaging
Market Restraints
Price Volatility of Pharmaceutical Packaging Raw Materials
Market Opportunities
Evolution of Nanotechnology due to Innovative and New Generation Packaging Solutions
Emergence of Sustainable and Eco-Friendly Packaging Solutions
Market Challenges
Stringent Regulatory Compliance
Market Segmentation Analysis
Type: Increasing preference for blister packs for pharmaceutical packaging due to resistance against humidity and contaminants
End User: Rising demand in pharmaceutical manufacturing for maintaining product integrity and extending shelf life
Market Disruption Analysis
Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Pharmaceutical Packaging Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Pharmaceutical Packaging Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Bormioli Pharma, Loop Partner on Pharmaceutical Packaging
Bormioli Pharma S.p.A. and Loop Industries, Inc. unveiled a pharmaceutical packaging bottle at the forefront of eco-innovation and safety, crafted from 100% recycled virgin quality Loop PET resin. As part of Bormioli Pharma's EcoPositive initiative, representing half of their standard product range, this collaboration is set to revolutionize sustainable packaging in the global pharmaceutical sector.
Stoelzle Pharma launches the PharmaCos packaging line
Stoelzle Pharma announced the launch of its PharmaCos Line, which is explicitly crafted for the well-being and healthcare sectors. This line offers an extensive array of glass jars and flat-shoulder bottles, varying from 5 ml to 500 ml in capacity, available in both amber and clear flint glass options.
PLUSS launches two new temp-controlled pharma packaging solutions
PLUSS Advanced Technologies (PLUSS) unveiled two innovative packaging solutions to revolutionize the pharmaceutical sector: the Celsure XL Pallet Shipper series and the Celsure VIP Multi-Use Parcel Shipper series. By introducing these solutions, PLUSS addresses a critical challenge in the Indian pharmaceutical industry: the need for reliable, high-quality passive shipping options that maintain consistent temperature control, a necessity for preserving the efficacy of pharmaceuticals.
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Pharmaceutical Packaging Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Pharmaceutical Packaging Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Amcor PLC, AptarGroup, Inc., Becton, Dickinson and Company, Berry Global, Inc., Catalent, Inc., CCL Industries Inc., Comar, LLC, Constantia Flexibles, Drug Plastics Group, EPL Limited, Gaplast GmbH, Gerresheimer AG, Klöckner Pentaplast Group, Lonza Group AG, McKesson Corporation, Mondi PLC, Nipro Corporation, Nolato AB, Origin Pharma Packaging, Schott AG, Sealed Air Corporation, SGD S.A., URSATEC GmbH, Vetter Pharma-Fertigung GmbH & Co. KG, W. L. Gore & Associates Inc., West Pharmaceutical Services, Inc., and Westrock Company by Smurfit Kappa Group.
Market Segmentation & Coverage
This research report categorizes the Pharmaceutical Packaging Market to forecast the revenues and analyze trends in each of the following sub-markets:
Type
Ampoules
Blister Packs
Caps & Closures
Cartridges
Labels & Accessories
Plastic Bottles
Pouches
Pre-Filled Inhalers
Pre-Filled Syringes
Vials
Delivery Mode
Injectables
IV Drugs
Nasal
Ocular
Oral
Pulmonary
Topical
Transdermal
Level of Packaging
Primary
Secondary
Tertiary
Material
Aluminum Foil
Glass
Paper
Plastics & Polymers
Polyethylene (PE)
Polyethylene terephthalate (PET)
Polypropylene (PP)
Polystyrene (PS)
Polyvinyl Chloride (PVC)
End User
Contract Packaging
Institutional Pharmacy
Pharmaceutical Manufacturing
Retail Pharmacy
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
Please Note: PDF & Excel + Online Access - 1 Year
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing Smart Packaging for Patient Engagement and Identification
5.1.1.2. Growing Demand for Primary Pharmaceutical Packaging
5.1.1.3. Increasing Demand for Biologics Packaging
5.1.2. Restraints
5.1.2.1. Price Volatility of Pharmaceutical Packaging Raw Materials
5.1.3. Opportunities
5.1.3.1. Evolution of Nanotechnology due to Innovative and New Generation Packaging Solutions
5.1.3.2. Emergence of Sustainable and Eco-Friendly Packaging Solutions
5.1.4. Challenges
5.1.4.1. Stringent Regulatory Compliance
5.2. Market Segmentation Analysis
5.2.1. Type: Increasing preference for blister packs for pharmaceutical packaging due to resistance against humidity and contaminants
5.2.2. End User: Rising demand in pharmaceutical manufacturing for maintaining product integrity and extending shelf life
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization
6. Pharmaceutical Packaging Market, by Type
6.1. Introduction
6.2. Ampoules
6.3. Blister Packs
6.4. Caps & Closures
6.5. Cartridges
6.6. Labels & Accessories
6.7. Plastic Bottles
6.8. Pouches
6.9. Pre-Filled Inhalers
6.10. Pre-Filled Syringes
6.11. Vials
7. Pharmaceutical Packaging Market, by Delivery Mode
7.1. Introduction
7.2. Injectables
7.3. IV Drugs
7.4. Nasal
7.5. Ocular
7.6. Oral
7.7. Pulmonary
7.8. Topical
7.9. Transdermal
8. Pharmaceutical Packaging Market, by Level of Packaging
8.1. Introduction
8.2. Primary
8.3. Secondary
8.4. Tertiary
9. Pharmaceutical Packaging Market, by Material
9.1. Introduction
9.2. Aluminum Foil
9.3. Glass
9.4. Paper
9.5. Plastics & Polymers
10. Pharmaceutical Packaging Market, by End User
10.1. Introduction
10.2. Contract Packaging
10.3. Institutional Pharmacy
10.4. Pharmaceutical Manufacturing
10.5. Retail Pharmacy
11. Americas Pharmaceutical Packaging Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Pharmaceutical Packaging Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Pharmaceutical Packaging Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. Bormioli Pharma, Loop Partner on Pharmaceutical Packaging
14.3.2. Stoelzle Pharma launches the PharmaCos packaging line
14.3.3. PLUSS launches two new temp-controlled pharma packaging solutions
14.3.4. Smurfit Kappa strikes deal to acquire WestRock